Average Co-Inventor Count = 3.49
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Miragen Therapeutics, Inc. (16 from 20 patents)
16 patents:
1. 10337005 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif
2. 10316318 - Oligonucleotide compositions and uses thereof
3. 10280422 - MiR-92 inhibitors and uses thereof
4. 10144930 - Inhibitors of MYH7B and uses thereof
5. 9994852 - Oligonucleotide compositions and uses thereof
6. 9994847 - miR-29 mimics and uses thereof
7. 9885042 - miR-92 inhibitors and uses thereof
8. 9803202 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif
9. 9771585 - miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)
10. 9752144 - Inhibitors of MYH7B and uses thereof
11. 9752143 - Locked nucleic acid inhibitor of miR-145 and uses thereof
12. 9416360 - Base modified oligonucleotides
13. 9388408 - Oligonucleotide-based inhibitors comprising locked nucleic acid motif
14. 9376681 - miR-29 mimics and uses thereof
15. 9163235 - Inhibitors of the miR-15 family of micro-RNAs